Ceftaroline-associated encephalopathy in patients with severe renal impairment.
Encephalopathy complicating beta-lactam therapy is well described, particularly with impaired renal function, though no studies have reported ceftaroline-associated encephalopathy. Among 28 patients with eGFR<30 who received ≥5 days of ceftaroline, we report three cases of encephalopathy. Ceftaroline, when dosed supra-therapeutically for serious infections, may be a cause of antibiotic-associated encephalopathy.